Roche Holding AG (OTCMKTS:RHHBY) Receives Average Rating of "Hold" from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have earned an average rating of "Hold" from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company.

Several equities research analysts recently commented on RHHBY shares. Sanford C. Bernstein raised shares of Roche to a "strong-buy" rating in a research report on Thursday, January 30th. Hsbc Global Res lowered Roche from a "strong-buy" rating to a "hold" rating in a report on Monday. HSBC downgraded shares of Roche from a "buy" rating to a "hold" rating in a report on Monday. Morgan Stanley assumed coverage on Roche in a report on Wednesday, February 12th. They set an "equal weight" rating on the stock. Finally, UBS Group raised Roche from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 13th.

Roche Stock Performance

RHHBY stock traded up $0.11 during mid-day trading on Monday, hitting $40.77. 1,719,082 shares of the company were exchanged, compared to its average volume of 3,062,785. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche has a 1-year low of $29.20 and a 1-year high of $44.31. The firm's 50 day simple moving average is $40.74 and its 200 day simple moving average is $38.61.

Institutional Trading of Roche

Institutional investors and hedge funds have recently bought and sold shares of the business. Moloney Securities Asset Management LLC raised its stake in Roche by 53.8% in the 1st quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company's stock valued at $1,672,000 after acquiring an additional 14,245 shares during the period. Altrius Capital Management Inc grew its stake in Roche by 3.6% in the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock valued at $7,818,000 after buying an additional 6,545 shares during the last quarter. Riverbridge Partners LLC raised its holdings in Roche by 6.7% in the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company's stock valued at $1,557,000 after acquiring an additional 2,381 shares during the period. Bard Financial Services Inc. boosted its holdings in shares of Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after acquiring an additional 28,050 shares during the period. Finally, GAMMA Investing LLC grew its position in shares of Roche by 59.5% in the first quarter. GAMMA Investing LLC now owns 12,850 shares of the company's stock valued at $529,000 after purchasing an additional 4,794 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.